Press release
PharmaResearch Accelerates Global Market Expansion with Investment from Global Private Equity Fund CVC
Image: https://www.getnews.info/uploads/37d3d1ec3a03e85dac6376b2c2e3bb4e.jpg
September 13th, 2024 - PharmaResearch (co-CEOs: Kang Ki Seock, Kim Thinkyou), a leader in aesthetic injectables and regenerative medicines renowned for its flagship skin booster product "Rejuran", announced a significant milestone in its global market expansion efforts, securing KRW 200 billion investment from Europe-based global private equity firm CVC through the issuance of redeemable convertible preferred shares (RCPS). Extending beyond capital injection, this investment will enable the company to accelerate overseas market entry through strategic partnership with CVC.
CVC is a leading global private equity firm that manages over 180 billion of AUM, and has a strong investment track record in the healthcare industry across Europe and other key global markets. PharmaResearch aims to leverage CVC's extensive global network and experience to achieve rapid and stable penetration into new international markets. As a strategic partner, CVC will provide valuable network and resources to support PharmaResearch's market expansion and strengthen the company's global competitiveness.
PharmaResearch plans to utilize the newly secured funds primarily for strategic overseas M&As and the establishment of local subsidiaries to implement region-specific go-to-market strategies and rapidly expand its presence in these markets. The company also intends to utilize the funds to upgrade its R&D capabilities and expand its product pipeline through acquisitions. Investments in innovative product development as well as existing product enhancements are expected to strengthen the company's product portfolio, leading to increased global competitiveness by delivering greater value to its international customers.
Kim Thinkyou, CEO of PharmaResearch, stated, "With CVC's investment and partnership, PharmaResearch is now in a stronger position to enhance its global market presence and continue focusing on developing innovative products and services. We are committed to delivering value to our customers and shareholders as we continue our journey towards becoming a global leader."
Kyoo-Cheol Chris Rhee, CVC's Head of Korea, remarked, "CVC is delighted to partner with a company like PharmaResearch." and added, "With our global network and experience, CVC is fully committed to supporting PharmaResearch's continued growth in the global market and to contributing to the growth of the K-beauty industry globally."
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT Registered PDRN and DOT Registered PN. These active tissue regenerative substances are powered by DOT Registered , an exclusive DNA fragments optimization technology safeguarded by a suite of patents. Headquartered in Seongnam, South Korea, PharmaResearch also operates a U.S. subsidiary, PharmaResearch USA, located in Costa Mesa, California. Key products include Rejuran Registered , Rejuviel Registered , Conjuran Registered , Rejuran Registered Cosmetics, Lian Registered Eye Drops, Rejuvenex Cream Registered , and Rejuderma Registered .
For more information about PharmaResearch and its innovative initiatives, visit http://pharmaresearch.co.kr/en/ and connect with us on LinkedIn [https://www.linkedin.com/company/pharmaresearch-corporation/].
Media Contact
Company Name: PharmaResearch USA
Contact Person: Sangjin Choi
Email: Send Email [http://www.universalpressrelease.com/?pr=pharmaresearch-accelerates-global-market-expansion-with-investment-from-global-private-equity-fund-cvc]
Country: United States
Website: http://pharmaresearch.co.kr/en
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PharmaResearch Accelerates Global Market Expansion with Investment from Global Private Equity Fund CVC here
News-ID: 3655392 • Views: …
More Releases from Getnews
Arshiner Launches Summer Adventure Apparel Collection, Integrating Functional Pr …
NEW YORK, NY - July 12, 2026 - Contemporary children's apparel brand Arshiner has officially unveiled its Summer Adventure Collection , a multi-scenario product line engineered to meet peak seasonal outdoor demand across North America. The collection directly addresses a critical parental demographic shift: the demand for high-performance, low-maintenance youth clothing that offers structural thermal regulation and ultraviolet protection without restricting biometric movement during high-energy activities like summer camps, sports,…
Let Kids Be Kids This Summer: Arshiner Launches Summer Adventure Collection for …
As the summer break peaks in North America, family road trips, summer camps, picnics, and parties fill the calendar. Yet with rising temperatures, parents often find themselves caught in a dilemma-they want their children to embrace the great outdoors, but worry about stuffy, restrictive clothing that traps heat and is difficult to clean afterward. How to let kids run wild without constraints has become the core challenge of summer dressing.
Image:…
97 Percent of Edmonton Businesses Are Invisible to ChatGPT, New Review Finds
Image: https://www.globalnewslines.com/uploads/2026/07/1783546111.jpg
A graphic reading "97% of Edmonton businesses are invisible to ChatGPT," based on Snap SEO's review of 150 Edmonton service businesses. Credit: Snap SEO.
A new review from Snap SEO finds that 97 percent of Edmonton service businesses are never mentioned when ChatGPT is asked for the best option in their category. The gap surfaces as Canada rolls out a national AI adoption strategy and Edmonton positions itself as a…
Richard E. Asphalt Paving Analyzes Foundations of Infrastructure Longevity in th …
Image: https://www.globalnewslines.com/uploads/2026/07/1783699786.jpg
Changing environmental conditions throughout Southwest Virginia place steady stress on transit surfaces, making proactive infrastructure maintenance vital. Richard E. Asphalt Paving has introduced an updated evaluation framework focused on subgrade compaction. This technical initiative targets previously undetected structural vulnerabilities in local residential and corporate pathways before heavy seasonal precipitation compromises their underlying stability.
Mitigating Subsurface Erosion and Water Infiltration
Water migration beneath pavement is a primary catalyst for asphalt failure. Minor…
More Releases for PharmaResearch
PharmaResearch Hosts 5th Global Symposium on 'Rejuran'
Over 600 Medical Professionals from 25 Countries Participate, Launch of IRC Committee for Rejuran Global Research Team
Image: https://www.getnews.info/uploads/184db9fd8e5f5bcffadcfd0b82962264.png
Seongnam, South Korea - PharmaResearch (CEO Ki Seock Kang and Thinkyou Kim) announced today that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on October 28-29, 2024. This year's event attracted approximately 600 aesthetic and medical professionals from 25 countries across Asia, the Americas, Europe, and the…
PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Fos …
Anticipating Collaborations with Leading Companies in Aesthetic Medical Devices, Pharmaceuticals and Biotechnology: Application Period August 15 - September 30
Image: https://www.getnews.info/uploads/3276751a42ffba8429fb959e81d25795.jpg
PharmaResearch, a company specializing in regenerative medicine (CEO Kim Thinkyou, Kang Ki-seock), announced that it will host the 'Open Innovation Day'. This initiative aims to foster collaborations in innovative technologies across the aesthetic medical device, pharmaceuticals, biotechnology sectors, both domestically and internationally.
PharmaResearch is seeking partnerships in several key areas, including -…
PharmaResearch Hosts Launch Symposium for REJURAN Registered HB Plus in Singapor …
Sharing information on DOT Trademark patented technology, distinctive efficacy, and safety
Image: https://www.getnews.info/uploads/a9dbc52352e6614785a6dbafd0148817.png
PharmaResearch (CEOs Kang Ki-seok and Kim Thinkyou), a company specializing in regenerative medicine, announced earlier this month that it held a launch symposium for REJURAN Registered HB Plus at Four Seasons Hotel in Singapore.
The symposium aimed to share the technological advancements and clinical experiences of REJURAN Registered HB Plus with local aesthetic experts and medical professionals.
Dr. Michael J. Kim,…
Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) Market Trends, Key Benefi …
Los Angeles, USA: QY Research has recently unveiled a comprehensive report titled, "Global Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) Market Report: Insights, Forecast to 2030." This detailed analysis examines the multiple elements shaping the future of the global Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) market.
The Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) report serves as an invaluable resource for industry players, providing precise and extensive research insights necessary for strategic decision-making. The analysts have…
PharmaResearch Presents 'REJURAN Registered ' as a New Solution for Flushing
Effective Use of PN for Flushing... Published in an SCIE-Level Journal
Image: https://www.getnews.info/uploads/52b03d248c2ca7ae3fdd1f69ef67ba5c.png
Flushing refers to the temporary or persistent redness of the skin on the face and neck. It occurs due to vasodilation and is known to arise from various causes, such as hormonal changes, sudden temperature fluctuations, inflammatory skin diseases, and prolonged laser treatments.
While laser and hormone therapies are common treatments for flushing, PharmaResearch(CEO Kim Thinkyou, Kang Ki-seok) has recently…
PharmaResearch, "Rejuran Registered " Accelerates Entry into Vietnam
Rejuran Launch Symposium Highlights Latest Aesthetic Trends and DOT Trademark Technology
Image: https://www.getnews.info/uploads/94717ca7a950a52ac08fd7e65857e556.jpg
PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced the official entry into the Vietnamese market through the 'Rejuran Launch Symposium' held on May 17 at the Intercontinental Vietnam.
The symposium was attended by over 400 Vietnamese aesthetic experts and medical professionals who validated the excellence of Rejuran and engaged in in-depth discussions on its application methods.
'Rejuran' is a medical device aimed…
